1. Cytokine-Based Immunotherapy for Advanced Kidney Cancer: Past Results and Future Perspectives in the Era of Molecularly Targeted Agents. (2007) Authors: Porta, Camillo; Paglino, Chiara; Imarisio, Ilaria; Bonomi, Lucia Other Names: Clark Peter E. Academic Editor. Journal: TheScientificWorldjournal Issue: Volume 7(2007) Page Start: 837 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Dovitinib (CHIR258, TKI258): structure, development and preclinical and clinical activity. (January 2015) Authors: Porta, Camillo; Giglione, Palma; Liguigli, Wanda; Paglino, Chiara Journal: Future oncology Issue: Volume 11:Number 1(2015) Page Start: 39 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Dovitinib (CHIR258, TKI258): structure, development and preclinical and clinical activity. (January 2015) Authors: Porta, Camillo; Giglione, Palma; Liguigli, Wanda; Paglino, Chiara Journal: Future oncology Issue: Volume 11:Number 1(2015) Page Start: 39 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. From the Zeno's paradoxes to novel immunotherapeutic agents for kidney cancer: moving from an era of wrong premises and conclusions to a better comprehension of immunology. (June 2013) Authors: Porta, Camillo; Ganini, Carlo; Paglino, Chiara Journal: Expert opinion on biological therapy Issue: Volume 13:Number 6(2013:Jun.) Page Start: 813 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Primary resistance to tyrosine kinase inhibitors in patients with advanced renal cell carcinoma: state-of-the-science. Issue 12 (December 2012) Authors: Porta, Camillo; Sabbatini, Roberto; Procopio, Giuseppe; Paglino, Chiara; Galligioni, Enzo; Ortega, Cinzia Journal: Expert review of anticancer therapy Issue: Volume 12:Issue 12(2012) Page Start: 1571 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Sunitinib in advanced metastatic non-clear cell renal cell carcinoma: a single institution retrospective study. (December 2012) Authors: Paglino, Chiara; Imarisio, Ilaria; Ganini, Carlo; Morbini, Patrizia; Vercelli, Alessandro; Bregant, Cristina; Porta, Camillo Journal: Future oncology Issue: Volume 8:Number 12(2012) Page Start: 1605 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Targeted therapy for renal cell carcinoma: focus on 2nd and 3rd line. (23rd March 2016) Authors: Porta, Camillo; Giglione, Palma; Paglino, Chiara Journal: Expert opinion on pharmacotherapy Issue: Volume 17:Number 5(2016) Page Start: 643 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. The effect of sorafenib treatment on the diabetic status of patients with renal cell or hepatocellular carcinoma. (August 2012) Authors: Imarisio, Ilaria; Paglino, Chiara; Ganini, Carlo; Magnani, Luigi; Caccialanza, Riccardo; Porta, Camillo Journal: Future oncology Issue: Volume 8:Number 8(2012) Page Start: 1051 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. The effect of sorafenib treatment on the diabetic status of patients with renal cell or hepatocellular carcinoma. (August 2012) Authors: Imarisio, Ilaria; Paglino, Chiara; Ganini, Carlo; Magnani, Luigi; Caccialanza, Riccardo; Porta, Camillo Journal: Future oncology Issue: Volume 8:Number 8(2012) Page Start: 1051 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗